Omar Ali-Hasan

Zurich, ZH 8091, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Journal: Cancers

Published: November 16, 2025

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis.

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis.

Journal: Journal for immunotherapy of cancer

Published: September 01, 2025

Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.

Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.

Journal: American journal of respiratory and critical care medicine

Published: April 16, 2024

Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Journal: Cancers

Published: January 31, 2024

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.

Journal: Acta neuropathologica communications

Published: December 19, 2023

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.

Journal: Journal of autoimmunity

Published: March 09, 2023

Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.

Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.

Journal: Med (New York, N.Y.)

Published: November 29, 2022

Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.

Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.

Journal: Science immunology

Published: September 02, 2022

Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.

Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.

Journal: Oncoimmunology

Published: December 03, 2021

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Journal: EMBO molecular medicine

Published: September 30, 2021

Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.

Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 22, 2021

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells.

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells.

Journal: Cell metabolism

Published: September 02, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026